Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by 2034, Fueled by Rising Demand for Non-invasive Options: Transparency Market Research, Inc. [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
WILMINGTON, Del. July 23, 2024 /PRNewswire/ -- The nasal polyposis treatment market was projected to attain US$ 3.5 billion in 2023. It is likely to garner a 6.3% CAGR from 2024 to 2034, and by 2034, the market for nasal polyposis treatment is expected to attain US$ 6.8 billion The emergence of biologic therapies targeting specific inflammatory pathways involved in nasal polyposis presents significant growth opportunities. Advances in personalized medicine approaches, tailoring treatments based on genetic and molecular characteristics, are expected to enhance treatment efficacy. Increasing patient preference for non-invasive or minimally invasive treatment options, such as intranasal corticosteroids and nasal sprays, drives market demand. Nasal polyposis often coexists with conditions like asthma and allergic rhinitis. Integrated treatment approaches that address these comorbidities are gaining traction. Make Smart Investment decisions with our data! Download a report sample to
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Sanford C. Bernstein from $133.00 to $138.00. They now have an "outperform" rating on the stock.MarketBeat
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $143.00 to $146.00. They now have a "buy" rating on the stock.MarketBeat
- Company News for Oct 17, 2024 [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Jefferies Financial Group Inc. from $120.00 to $125.00. They now have a "hold" rating on the stock.MarketBeat
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 10/16/24 - Form 8-K
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website